Advisory Board and Editors Translational Medicine

PeerJ Factsheet
A one-page facts and stats PDF, to help when considering journal options with your co-authors.
Download Factsheet
I told my colleagues that PeerJ is a journal where they need to publish if they want their paper to be published quickly and with the strict peer review expected from a good journal.
Sohath Vanegas,
PeerJ Author
View author feedback

Sarwat Naz

Dr. Naz obtained her PhD degree in 2013 from Indian Institute of Science, India. She then moved to USA to conduct her postdoctoral training. She is currently a Scientist at National Cancer Institute at NIH, USA where she conducts clinical and translational research in the field of cancer. Her primary research focus is identification of means to modify the radiation response of tumors without causing damage to surrounding normal tissues. Her research utilizes testing novel agents that target specific molecular pathways important in radiation responses to probe the radio sensitivity of cells/tissues. In her current role at NCI she manages translational research initiatives involving radiation modification, the influence of tumor microenvironment on cancer immunotherapy, and novel molecular imaging platforms to assess tissue metabolism.

Audrey R Odom John

Chief, Division of Infectious Diseases, Children's Hospital of Philadelphia

The primary research goals of our lab are to understand the biological functions of specific metabolic pathways in the malaria parasite--that is, to understand what the parasite needs to make, and why it needs to make it.

Anurag N Paranjape

Passionate about understanding the mechanisms governing cancer metastasis with a hope of finding new targetable pathways. Have worked on breast cancer stem cells, EMT, prostate cancer stem cells, breast cancer brain metastasis, and blood-brain barriers.

Kevin Petrie

I obtained my PhD from the Institute of Cancer Research in London spent a further 10 years there as a postdoctoral fellow and Staff Scientist. I am currently a Lecturer in Molecular Biology at the University of Stirling in Scotland. My principal research interest is translational oncology, with a focus on epigenetics.

Rafael Radi

Professor and Chairman of Biochemistry, Facultad de Medicina, Universidad de la República, Uruguay. Discovery Award of the Society for Free Radical Biology and Medicine (SFRBM, 2011), Alexander Von Humboldt Senior Award (2010), National Prize in Science and Technology (2007). Howard Hughes International Research Scholar (2000-2011). Past-President of SFRBM and of the Society for Free Radical Research International. Foreign Associate of the US National Academy of Sciences (2015). Founding Member and current President of the Academia Nacional de Ciencias del Uruguay.

Thomas Ritter

Prof Thomas Ritter, leader of research programme, was recruited by the National University of Ireland, Galway as a lecturer in Gene Therapy and Regenerative Medicine and assumed his position in March 2005. Prof. Ritter has over 20 year experience in the field of gene therapy in organ transplantation. He obtained his Ph.D. degree in 1994 from the Max-Planck Research group of Immunology / Rheumatology at the University of Erlangen-Nuremberg, Germany where he worked on the molecular characterization of T cell receptors specific for human collagen type II. Having completed his Post-Doctoral Fellowship at Marseille, Center of Immunology in 1995, Prof. Ritter took up a faculty position at the prestigious Charité University Hospital in Berlin, Germany. He worked as a leader of the gene therapy programme in experimental transplantation in the Institute of Medical Immunology under the directorship of Prof. Dr. H.-D. Volk. His research focused on the development of efficient viral gene-transfer systems for application in transplantation medicine. Prof. Ritter was successful in obtaining funding from the German Research Foundation and the Ministry of Health and Research as well as from industry (Schering). Prof. Ritter completed his 'Habilitation' (postdoctoral lecture qualification) in Immunology in 2002 followed by a promotion to assistant professor in 2003.

Michael A. Rogawski

Professor, Department of Neurology, School of Medicine; Pharmacology and Toxicology Graduate Group; Center for Neuroscience; University of California, Davis. Past president, American Society for Experimental NeuroTherapeutics. Academic editor of 9 journals. Co-founder of Epilepsy Currents, the journal of the American Epilepsy Society.

I received a B.A. (biophysics) from Amherst College, and M.D. and Ph.D. (pharmacology) degrees from Yale University. I was a resident, fellow and assistant professor in the Department of Neurology at the Johns Hopkins University School of Medicine. For over 20 years, I was a senior investigator and chief of the Epilepsy Research Section at the National Institute of Neurological Disorders and Stroke. My research interests involve ion channel pharmacology and neurological therapeutics, including antiepileptic drugs and other epilepsy treatment approaches.

Claudia Scholl

Claudia Scholl is head of the Division Applied Functional Genomics at the German Cancer Research Center (DKFZ) and National Center for Tumor Diseases Heidelberg (NCT), Heidelberg, Germany. She went to medical school in Heidelberg and Ulm, and following her residency in Internal Medicine, she trained as a postdoctoral fellow at Brigham and Women’s Hospital and Harvard Medical School in Boston, USA. Her research interests include the identification of vulnerabilites in cancer cells that might be exploited for the development of targeted therapies with focus on KRAS mutant cancers and AML.

Teresa M Seccia

Associate Professor in Internal Medicine, Dept. Medicine, University of Padova, Italy.
International PhD Degree in 'Arterial Hypertension and Vascular Biology'.

Field of interest: Clinical and translational research in high blood pressure and cardiovascular diseases.

Sahil Seth

Computational (Biologist), Scientist at MD Anderson Cancer Center.
Made contributions to several large scale cancer genomic studies, as part of The Cancer Genome Atlas (TCGA) project.
Interested in studying evolutionary dynamics in cancer, understanding resistance mechanisms and inform on targetted therapies.
Developing methods to enhance integrative analysis of large-scale genomic datasets.
Avid proponent of open-source software, with a few packages on CRAN.

Gaurav Sharma

Gaurav Sharma is a biomedical researcher with expertise in intermediary metabolism and metabolic imaging. His long-term research interests are the development of magnetic resonance spectroscopy/imaging (MRS/I) techniques for the noninvasive investigation of metabolic processes under both normal and pathologic conditions that can be applied in preclinical and clinical settings. Gaurav's current research focus is mainly in two areas: first, development of novel methods for non-invasive assessment of metabolism and second, understanding the intermediary metabolism in biological systems. In particular, his research involved the use of dynamic nuclear polarization to increase the MR signal of metabolically active, 13C-labeled probes for accessing metabolism in isolated perfused organs and in vivo metabolic imaging, and 13C-NMR isotopomer analysis for assessing in vivo metabolic flux.

Shi-Cong Tao

Shanghai Jiao Tong University Affiliated Sixth People’s Hospital.
His current research interests include extracellular vesicles, micro- and nano-biomaterials, regenerative medicine, tissue engineering, osteosarcoma, osteoarthritis and osteoporosis.

Special Issues (Guest Editor):
1. BioMed Research International, Lead Guest Editor, Special Issue on "A Novel Role for Extracellular Vesicles in Cytopathology and New Therapeutic Strategies",
2. Topic Editor (Frontiers in Bioengineering and Biotechnology, Frontiers in Molecular Biosciences), Research Topic on "Microfluidic Organ-on-a-Chip: Revolutionary Platforms for Disease Comprehension and Treatment",

Editorial Board Memberships:
BMC Musculoskeletal Disorders, Associate Editor, 2019 - now
Frontiers in Medicine, Associate Editor in Translational Medicine, 2019 - now
Frontiers in Medicine, Review Editor for Translational Medicine, 2018 - 2019
PeerJ, Academic Editor, 2018 - now